Purpura Fulminans – A Rapidly Progressive Coagulopathic Emergency Across The Lifespan
Indunil Karunarathna, Consultant Anaesthetist, Head of the Department, T H Polonnaruwa, Ministry of Health, Sri Lanka, posted on LinkedIn:
”Purpura fulminans is a rare but profoundly life-threatening clinical syndrome characterized by explosive onset of microvascular thrombosis, hemorrhagic infarction of the skin, and, in many cases, disseminated intravascular coagulation. Although it may present in neonates, children, or adults, its pathobiology varies widely according to the underlying mechanism and is classically categorized into neonatal, idiopathic/post-infectious, and acute infectious forms.
Despite distinct etiologies – including genetic deficiencies of natural anticoagulants, autoimmune destruction of protein S, or consumptive coagulopathy in severe sepsis – the final common pathway is a catastrophic imbalance in hemostasis favoring uncontrolled coagulation.
Clinically, patients rapidly progress from erythematous lesions to purpuric patches, hemorrhagic bullae, and full-thickness necrosis, often accompanied by multiorgan dysfunction.
Early recognition, rapid workup for infection and coagulopathy, and immediate initiation of targeted therapy – including anticoagulation, protein C replacement, antimicrobial therapy, immunomodulation, and surgical debridement – are essential to improve survival.
Although modern intensive care has reduced mortality, survivors frequently experience permanent disability, making purpura fulminans a condition that demands high clinical vigilance and an integrated, multidisciplinary response.”
Read the full article here.
Title: Purpura Fulminans A Rapidly Progressive Coagulopathic Emergency Across The Lifespan
Author: Indunil Karunarathna

Stay updated with Hemostasis Today.
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
-
Jul 16, 2026, 18:40Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026